Article Information

Sanjay Prabhu1
Nasreen Mahomed2

1Department of Radiology, Boston Children’s Hospital, Harvard Medical School, United States of America

2Department of Diagnostic Radiology, University of the Witwatersrand, South Africa

Correspondence to:
Sanjay Prabhu


Postal address:
Private Bag X3, University of the Witwatersrand, Johannesburg 2050, South Africa

Received: 01 Sept. 2015
Accepted: 15 Oct. 2015
Published: 09 Dec. 2015

How to cite this article:
Prabhu S. & Mahomed N. ‘Imaging of intractable paediatric epilepsy’. S Afr J Rad. 2015;19(2): Art. #936, 10 pages.

Copyright Notice:
© 2015. The Authors. Licensee: AOSIS OpenJournals.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Imaging of intractable paediatric epilepsy
In This Review Article...
Open Access
   • Phases in the evaluation of children with epilepsy
      • Phase 1
      • Phase 2
      • Phase 3
      • Phase 4
Imaging techniques
Optimisation of epilepsy protocols using 1.5T MRI scanners
New techniques used on 3T MRI scanners
Reviewing an MRI for childhood epilepsy: A systematic approach
Features of common epileptogenic substrates
   • Focal cortical dysplasia
   • Mesial temporal sclerosis
   • Sturge-Weber syndrome
   • Tuberous sclerosis complex
   • Rasmussen encephalitis
   • Neoplastic lesions
   • Perinatal stroke
   • Post-traumatic epilepsy
Pitfalls and traps
Putting it all together
   • Competing interests
   • Authors’ contributions

Approximately 20% of paediatric patients with epilepsy are refractory to medical therapies. In this subgroup of patients, neuroimaging plays an important role in identifying an epileptogenic focus. Successful identification of a structural lesion results in a better outcome following epilepsy surgery. Advances in imaging technologies, methods of epileptogenic region localisation and refinement of clinical evaluation of this group of patients in epilepsy centres have helped to widen the spectrum of children who could potentially benefit from surgical treatment. In this review, we discuss ways to optimise imaging techniques, list typical imaging features of common pathologies that can cause epilepsy, and potential pitfalls to be aware of whilst reviewing imaging studies in this challenging group of patients. The importance of multidisciplinary meetings to analyse and synthesise all the non-invasive data is emphasised. Our objectives are: to describe the four phases of evaluation of children with drug-resistant localisation-related epilepsy; to describe optimal imaging techniques that can help maximise detection of epileptogenic foci; to describe a systematic approach to reviewing magnetic resonance imaging of children with intractable epilepsy; to describe the features of common epileptogenic substrates; to list potential pitfalls whilst reviewing imaging studies in these patients; and to highlight the value of multimodality and interdisciplinary approaches to the management of this group of children.


Approximately 20% of children with epilepsy are refractory to medical therapy, which has a significant adverse effect on patients and their families.1 The term ‘drug-resistant epilepsy’ has been proposed by the International League against Epilepsy (ILAE) to replace terms such as refractory and intractable epilepsy. Neuroimaging plays an important role in identifying epileptogenic foci that can be surgically resected. Advances in neuroimaging, including advances in scanner hardware and software, have allowed improved signal-to-noise ratio and achieve faster scan times and fewer motion artifacts. In addition, use of advanced imaging techniques, including multimodality fusion, has enabled improved lesion detection and localisation. It is important to choose tests based on their potential to further define the epileptogenic region, acknowledge their known strengths and limitations, and weigh the expected clinical benefit and incremental cost-effectiveness. Any additional test should be chosen on the basis of the likelihood that it can change the resection plan or surgical method. It should be pointed out that a review in 2011 by an ILAE panel found no studies that qualified as class 1 evidence, and little class 2 evidence on the utility of diagnostic tests in pre-surgical evaluation of patients with pediatric epilepsy.2 Recommendations provided in the present review are based on the first author’s personal experience of working in paediatric epilepsy groups over the last decade and is similar to consensus recommendations from various ILAE panels.3

Phases in the evaluation of children with epilepsy

Phase 1

One must first define the seizure syndrome and ensure that medical therapy is optimised; this includes a detailed history, including pre- and postnatal events, seizure history including the semiology (type of seizure), characteristics of onset and manifestations of the seizures, a full neurological examination, detailed electrophysiology via several electroencephalography (EEG) exams that record interictal and ictal events, and neuroimaging.

Functional imaging with single-photon emission computed tomography (SPECT) and/or positron emission tomography (PET), functional magnetic resonance imaging (fMRI) and magneto encephalography (MEG) are also used in some cases. Results are discussed at multidisciplinary team meetings involving specialists in neurology, neurosurgery, neurophysiology, neuroradiology and neuropsychology. If the anatomical and functional images are concordant with the seizure semiology and information gathered is considered adequate, surgical resection may be planned. If there is no concordance of data, further testing may be required, such as hospital admission for continuous scalp EEG or video-telemetry to better define the seizure frequency and semiology, particularly if the seizures are predominantly nocturnal or ill-defined on routine EEG. Neuropsychological testing helps to assess baseline performance, the level of neurodevelopment, deficits in various domains including verbal and non-verbal communication, and psychosocial factors. This evaluation helps in documenting the extent of premorbid damage and predicting possible outcomes following epilepsy surgery.

Phase 2

Invasive monitoring is used to further lateralise and localise the seizure focus that remains incompletely defined by noninvasive studies in Phase 1 or to determine the location of the seizure focus relative to eloquent cortex.

Phase 3

Comprehensive review of the data is done by the epilepsy team, to confirm concordance of findings; and to decide if surgery is the best option (either curative or palliative).

Phase 4

The postoperative assessment is routinely performed 6–24 months after the surgical procedure to document the final outcome.

Imaging techniques

Neuroimaging is recommended when localisation-related epilepsy is known or suspected, when the epilepsy classification is in doubt, or when an epilepsy syndrome with remote symptomatic cause is suspected. MRI is the modality of first choice. Aims of structural imaging include locating the epileptogenic region, providing a surgical planning map, defining the relation of a focal lesion to eloquent areas, and as a base for functional studies including PET, SPECT, fMRI and MEG.

In the last decade, advances in scanner hardware and software have improved the rate of detection of epileptogenic lesions. Wherever possible, a high-resolution protocol on a 3T scanner is preferred as it improves the pre-surgical evaluation in focal epilepsies. As 3T MRI scanners are rarely available in developing countries, epilepsy protocols should be optimised when using 1.5T.

Although outcomes are improved after complete resection of cortical dysplasia, microscopic cortical dysplasia can be found in adjacent areas of the brain, which may be epileptogenic and not visualised on MRI. Specifically epilepsy-tailored protocols on both 1.5T and 3T scanners can improve detection of focal cortical dysplasia (FCD) and other epileptic substrates. The literature has demonstrated that the ‘catch rate’ of epilepsy protocols is appreciably higher than conventional ‘brain screen’ protocols (72% v. 49% and 91% v. 50%).4,5

Based on the recommendations by consensus panels of the ILAE3 and the author’s personal experience, the following MRI protocol sequences are recommended in children with epilepsy, irrespective of the strength of the MRI scanner (Box 1).

BOX 1: Recommended MRI protocol for epilepsy at 1.5T and 3T.

Optimisation of epilepsy protocols using 1.5T MRI scanners

With 3T MRI scanners, a 3D sagittal fluid-attenuated inversion recovery (FLAIR) with multiplanar reformats is recommended to look for focal cortical dysplasia. In lieu of this, a coronal FLAIR can be used at 1.5T scanning the whole brain. Thin section, no-gap axial T2 (3 mm – 4 mm thick slices) is recommended. Increasing the number of averages or number of excitations to increase the signal-to-noise ratio at 1.5T may be employed; this generally means a longer scan time and may call for sedation of younger patients. A susceptibility-weighted imaging (SWI) or gradient echo sequence can be added to the protocol in populations with higher incidence of calcified lesions such as tuberculomas and in patients with neuro-cutaneous syndromes.

New techniques used on 3T MRI scanners

Isotropic motion-compensated multi-echo T1W magnetisation-sprepared rapid gradient echo allows optimal characterisation of the cortical outline in three planes. The author includes a diffusion tensor imaging sequence (35 diffusion directions, 3 mm slice thickness, b value of 0 and 1000 seconds/mm2) in all patients to produce tractography maps for surgical planning in patients with lesions in eloquent areas and arterial spin labelled images to assess perfusion without the need for a contrast medium. MR spectroscopy and contrast-enhanced imaging is reserved for selected cases.

Reviewing an MRI for childhood epilepsy: A systematic approach

Axial and coronal T2-weighted images are usually the starting point to look for cerebral hemispheric asymmetry (both size and signal intensity), gyral folding pattern, blurring of the gray and white matter junction, and symmetry of the white matter signal. Following this, volumetric T1W images are reviewed and assessed for midline structures including the hypothalamic region, gyral folding pattern, cortical thickness, sulcal asymmetry, uniformity of cortical signal, and subcortical and periventricular gray matter lesions. Finally, the hippocampi and temporal lobes are reviewed in detail.

At this point, available EEG reports and the seizure semiology are reviewed and, based on this information, the areas of concern are reassessed on MRI.

Features of common epileptogenic substrates

Focal cortical dysplasia

The ILAE describes three types of focal cortical dysplasia (FCD) and the corresponding subtypes as follows:6

  • FCD Type I – Type 1A: abnormalities of cortical lamination (Figure 1). Type 1B: abnormal tangential cortical lamination. Type 1C: abnormal radial lamination.

    FIGURE 1: Three-year-old girl with pharmaco-resistant left frontal lobe epilepsy. Axial T2W (a) shows focal thickening of the cortex in the posterior orbital gyrus in the left inferior frontal lobe (arrow) extending into the anterior aspect of the insula and inferiorly to the junction of the insula and anterior aspect of the superior temporal lobe gyrus. Coronal MPRAGE (b); note the mildly increased T1 signal of the affected cortex and blurred gray and white matter interface (arrowhead). Resected specimen showed focal regions of dyslamination of the cortex and moderate to severe reactive gliosis in keeping with FCD Type 1A.

  • FCD Type II – Type IIA: abnormal cortical dyslamination and dysmorphic neurons without balloon cells. Type IIB: with balloon cells (Figure 2).

    FIGURE 2: Twenty-month-old child with drug-resistant seizures from birth. Coronal (a) and axial (b) T2W show left frontal cortical dysplasia characterised by cortical thickening and adjacent white matter abnormality extending to the ventricular margin (arrows). Note the mineralisation indicated byT2 hypointensity in the left subcortical white matter (arrowhead). Resection specimen revealed Palmini Type IIB focal cortical dysplasia and coexisting low-grade astrocytoma. Proximity of the posterior margin of the lesion to the central sulcus made surgical resection challenging in this patient.

  • FCD Type III – Type IIIA: includes FCDs with an associated lesion such as hippocampal sclerosis (Figure 3). Type IIIB: an epilepsy-associated tumour. Type IIIC: vascular malformation. Type IIID: other lesions.

    FIGURE 3: Nine-year-old child with a year-long history of refractory generalised tonic-clonic seizures after cigarette olfaction aura. Axial FLAIR shows enlargement of the left temporal lobe compared with the right; abnormal signal intensity within the thickened cortex; and loss of gray and white matter differentiation (arrow). Pathology of the resected specimen revealed focal cortical dysplasia type 1 with hippocampal sclerosis, consistent with Type IIIA FCD as per the latest FCD classification.

Features of FCD on MRI include cortical thickening (which should be confirmed in at least two planes and on two different imaging sequences), blurring of the gray and white matter junction, T2 and FLAIR hyperintensity in the cortex and adjacent subcortical white matter, T1 shortening in the cortex and abnormal sulcal/ gyral pattern. MRI is able to show abnormalities in the majority of Type II dysplasias but only in some of the Type I cortical dysplasias although, in practice, it may be possible to distinguish between Type I and Type II.7 The typical appearance of FCD Type IIB (with balloon cells) is a band of hyperintensity on T2-weighted and FLAIR images extending from the gray and white matter interface to the surface of the ventricles (Figure 2). To visualise this often subtle finding, multiplanar thin-section images should be performed. At 3T, volumetric FLAIR with multiplanar reformats is an excellent sequence to look for the white matter hyperintensity characteristic of Type II FCDs.

Mesial temporal sclerosis

Mesial temporal sclerosis (MTS) is an uncommon finding in children. Although some studies have shown a high correlation with epilepsy, hippocampal atrophy and T2 prolongation can also be seen in asymptomatic subjects.8,9 An important factor that contributes to earlier detection of mesial temporal sclerosis in children is the use of dedicated epilepsy protocols which include thin-section coronal T2 and FLAIR perpendicular to the hippocampus. An initial event such as prolonged febrile seizures, prior infection, trauma, factors that increase vulnerability to neuronal injury such as hippocampal dysgenesis together with genetic predisposition are thought to work in tandem for MTS to develop. The author has reported on young children presenting with seizures that are accompanied by diffusion restriction in the hippocampus acutely followed by development of MTS within the next 2 years.10 Findings that suggest MTS include: hippocampal T2 hyperintensity, reduced hippocampal size, loss of hippocampal interdigitations, atrophy of the collateral white matter, reduced gray and white matter differentiation in the anterior temporal lobe, decreased temporal lobe size, and ipsilateral temporal horn enlargement (Figure 4).

FIGURE 4: Three-year-old girl with mesial temporal sclerosis. Coronal T2W images demonstrate T2 prolongation and loss of volume within the left hippocampus (a) (arrow). Note also the blurring of the gray and white matter in the left temporal lobe (b) (arrowhead).

MTS is widely acknowledged to be a progressive disease; however, the secondary signs of MTS including ipsilateral fornix and mammillary body atrophy are very uncommon in children. It is important to look for dual pathology including cortical dysplasia and neoplasms, as the prevalence of dual pathology after temporal lobe resection has been reported to range between 12% and 79%.11,12,13 It is also necessary to evaluate for bilateral MTS as this can change the management plan, particularly in patients with bilateral seizures and bilateral EEG abnormalities.

Other techniques with varying degrees of success have been described, including voxel-based morphometry, voxel-based diffusion tensor imaging and T2 relaxometry analysis to detect MTS, but are not routinely used.14,15,16 Sub-millimetre-high resolution scans using 64- and 128-channel coils are being investigated by various groups including the author’s, as earlier detection and treatment of MTS can help to reduce the cognitive and developmental morbidity in these children.

Sturge-Weber syndrome

Sturge-Weber syndrome (SWS) is a neurocutaneous disorder clinically characterised by epilepsy, progressive mental retardation, and facial telangiectatic nevi, often in the trigeminal nerve distribution. MRI is the most useful imaging study in the first year of life, as an abnormal scan is the best predictor of adverse clinical outcomes in these patients. Most authors agree that a gadolinium-enhanced brain MRI should be performed within the first 3 months of life, with the caveat that a negative result should not be considered conclusive if neurological symptoms develop.17 On MRI, the main findings of SWS are cerebral atrophy, white matter abnormalities in the region of the leptomeningealangiomatosis, hypertrophy of the overlying calvarium, and congested deep cerebral veins. Contrast should always be used when evaluating a child with suspected SWS to demonstrate the enhancement of the superficial gyri and define the extent of leptomeningeal vascular abnormality, even before the rest of the abnormalities become visible (Figure 5).18 MRI perfusion studies are useful in detecting perfusion defects. Assessment of the contralateral hemisphere is especially important as bilateral involvement is well recognised.

FIGURE 5: An 8-month-old girl with bilateral facial port-wine stains, seizures and congenital glaucoma. Axial T2W (a) demonstrates cerebral atrophy. Contrast-enhanced axial T1W (b) shows leptomeningeal enhancement involving both cerebral hemispheres, left side (arrowheads) greater than right (arrows), consistent with bilateral Sturge-Weber syndrome.

Tuberous sclerosis complex

Tuberous sclerosis complex (TSC) is a multisystem genetic disorder of variable phenotypic expression, with an incidence of about 1 in 5800 live births worldwide.19 The disorder results from a mutation in the TSC1 gene in chromosomal region 9q34 or the TSC2 gene in chromosomal region 16p13, and is inherited in an autosomal dominant fashion. Up to two-thirds of cases result from spontaneous genetic mutation. Clinical manifestations of tuberous sclerosis include seizures, autism, developmental delay, and behavioural and psychiatric disorders. Epilepsy is common in patients with TSC, occurring in up to 90% of affected individuals during their lifetime.19 Up to one-third of children will develop infantile spasms. Although not completely understood, the incidence of epilepsy is thought to relate to the neuropathologic features of the disorder, including cortical tubers and other dysgenetic features. Individuals with TSC frequently have epileptiform features on their electroencephalograms. In addition to medical therapies, surgery plays an important role in the management of children with drug-resistant epilepsy in TSC. The focus of pre-surgical evaluation in these patients is to identify the most epileptogenic tubers by multimodality non-invasive tests, including using a combination of MRI (Figure 6), PET (including [(11) C] methyl-l-tryptophan-positron emission tomography [AMT-PET]), ictal and interictal SPECT, and MEG. Based on this evaluation, a subset of patients with TSC can become suitable candidates for surgical resection. In some cases, subdural electrode placement may be required to identify a single or conglomerate of epileptogenic tubers.

FIGURE 6: Axial T2W demonstrates multiple tubers and white matter lesions. Note how the subcortical tuber is associated with linear white matter high signal that tracks towards the ventricle (arrow). Also note the hypointense subependymal nodule (arrowhead).

Rasmussen encephalitis

Rasmussen encephalitis is a rare chronic progressive encephalitis characterised by drug-resistant epilepsy (including partial seizures and epilepsy partialis continua) with unilateral brain atrophy on imaging studies. In the acute stage, imaging studies can be normal or demonstrate gyral swelling without enhancement. As the disease progresses, there is progressive volume loss and abnormal T2W and FLAIR hyperintensity within the white matter and cortex (Figure 7). A study by our group found the 2005 Bien diagnostic criteria for Rasmussen encephalitis to have reasonably high sensitivity and specificity and good clinical-pathologic correlation in most cases.20

FIGURE 7: Twelve-year-old girl with drug-resistant complex partial seizures. Serial axial T2W images obtained at presentation (a) followed by serial studies at 1 year (b) and 2 years (c) after presentation show unilateral progressive frontal and temporal atrophy as indicated by prominence of the sulci and ventricles. Note that there is no appreciable signal abnormality in the caudate head, but the ipsilateral (left-sided) basal ganglia are slightly smaller than those on the right on all three images.

Neoplastic lesions

Neoplastic lesions associated with drug-resistant epilepsy are usually cortically based and may remain indolent for many years prior to presentation. The vast majority of tumours are located in the temporal lobe and the most frequent tumour type is aganglioglioma, followed by pilocyticastrocytomas and dysembryoplastic neuroepithelial tumors (DNET) (Figure 8).21 In addition to imaging and characterising the tumour, it is important to evaluate for coexisting pathology, such as mesial temporal sclerosis in cases of temporal lobe neoplasms. The epileptogenic area should carefully be determined by non-invasive and/or invasive EEG recordings of the zone of seizure onset and persistent interictal activity. Also, imaging in many cases includes functional studies including functional MRI and/or the Wada test. Based on this pre-surgical evaluation, complete resection of the tumour and any surrounding abnormalities helps to reduce seizure frequency in a large number of cases. Follow-up studies should be tailored to evaluate for tumour recurrence (and therefore necessitating use of contrast medium in most cases) and residual abnormalities in cases where seizure reduction does not occur as expected.

FIGURE 8: Three-year-old boy presenting with new onset seizures. Axial T2W (a), MPRAGE (b) and contrast-enhanced MPRAGE (c) demonstrate focally thickened cortex in the left parietal lobe with slightly T2 hyper- and T1 isointense signal of the thickened cortex in the left postcentral gyrus (arrows). Although this could be a focal cortical dysplasia, the presence of blush of enhancement (arrow) on the contrast-enhanced sequence (c) raises concerns of a neoplastic process. Pathology of the resected specimen (after initial biopsy) showed an angiocentric glioma.

Perinatal stroke

There is a significant risk of developing epilepsy after perinatal stroke, hypoxic-ischaemic injury, and intracerebral haemorrhage (Figure 9). Seizures can become refractory to medications in approximately 25% of these patients.22 Challenges in managing seizures in these patients include multifocal or bilateral cortical injury, non-focal or poorly lateralising video electroencephalography (EEG) findings, and limited functional reserve. Seizure onset zone may not be limited to the abnormality identified on imaging studies, and subdural electrode placement for invasive monitoring may be required. In addition to acquiring a functional MRI, we track the corticospinal, visual and language pathways using diffusion tensor imaging and tractography to aid the neurosurgeon in developing a resection plan. When surgical resection is planned using this approach, functional outcomes are generally good in this group of patients, with improvements in independence, quality of life, cognitive development and motor skills, despite transient postoperative monoparesis or hemiparesis and occasional mood disorders.

FIGURE 9: An 8-year-old girl with drug-resistant epilepsy since age 2. Axial T2W demonstrates cystic encephalomalacia in the left middle cerebral artery territory related to remote infarction involving the left temporal lobe, insula, left frontal and parietal regions. Note ex vacuo dilatation of the left lateral ventricle (arrow), Wallerian degeneration of the cerebral peduncle and encephalomalacia of the left thalamus.

Post-traumatic epilepsy

Seizures and epilepsy are relatively common in children with post-traumatic brain injury (TBI) and portend worse functional outcome.23 The exact pathogenesis of post-traumatic seizures and epilepsy is not well understood, but the window of development of epilepsy after TBI can last up to 10 years or longer after the event.24 It is important to consider post-traumatic epilepsy even in cases where a recent history of trauma is not forthcoming or if the imaging findings seen during a workup for seizures include evidence of trauma such as hemosiderin staining or focal encephalomalacia. Areas of damage that may not be apparent on studies obtained at the time of prior trauma (usually CT scans in the acute period) include the inferior frontal and temporal lobes, which are affected as a result of the contracoup mechanism following trauma over the lateral convexities (Figure 10). Susceptibility-weighted images should be included to increase sensitivity of the study for hemosiderin at sites of prior injury. Post-traumatic seizures may be associated with other pathological changes seen following brain trauma such as reactive gliosis, Wallerian degeneration, microglial scar formation, and cystic white matter lesions. Some of these pathologies have imaging correlates. Studies suggest that post-traumatic seizures may be a result of alterations of intrinsic membrane properties of pyramidal neurons together with enhanced N-methyl-D-aspartate (NMDA) synaptic conductance.23,24

FIGURE 10: Sixteen-year-old girl with history of traumatic head injury 5 years prior to the current study presented with refractory temporal lobe epilepsy. Coronal T2W demonstrates gliosis in the anterior inferior frontal lobes and anterior right temporal pole (arrow). Resection of the anterior right temporal lobe resulted in cessation of her epileptic seizures.

Pitfalls and traps

A few pitfalls and pointers are worth mentioning when reviewing scans of children with drug-resistant epilepsy. These include the following:

  1. Normal variants can be problematic, particularly in the temporal lobes; for example, incomplete inversion of the hippocampus can be seen in asymptomatic individuals.

  2. Dual pathology has been reported in approximately 15% of patients. In view of this finding, a careful review should be carried out even if a lesion is identified in the initial phase of the scan review. In cases with a convincing unihemispheric abnormality, it is extremely important to review the contralateral hemisphere for subtle anomalies as this may alter management.

  3. Neoplastic lesions can masquerade as cortical dysplasia. Clinically, this should be suspected in cases where seizures are of relatively recent onset, and on imaging when cortical thickening is accompanied by large overlying vessels with avid lesion enhancement post contrast.

  4. There are documented cases, albeit rare, where the detected lesion was unrelated to the ER. The presence of multiple lesions (e.g., tuberous sclerosis or nodular heterotopias) does not necessarily mean that seizures are multifocal in onset.

  5. Focal lesions, particularly FCDs, can be masked between the ages of 6 months and 2 years owing to incomplete myelination. In these cases, repeat imaging is recommended every 3–6 months and, if tolerated, after 2 years of age. Also, one should evaluate any scans available from the neonatal period, as these may reveal the extent of cortical malformations of cortical development (such as polymicrogyria) before myelination commenced.

  6. One of the dangers of focusing attention on a particular suspect location is that it can lead to elevated sensitivity at the cost of diminished specificity. Therefore, it is advisable to make a concerted attempt to exclude other lesions elsewhere at similar sensitivity thresholds.

  7. In MRI-negative patients with drug-resistant epilepsy, serial assessment is advised to document temporal consistency of localisation and attempt to exclude other aetiologies such as genetic/idiopathic (e.g. SCN1A epilepsies), auto-immune (e.g. NMDA), voltage gated potassium channel (VGKC), and neurodegenerative syndromes. Repeat MRI should be considered after completion of myelination around 2 years, preferably on a 3T scanner. In non-lesional cases, one or more ancillary tests are required to allow a hypothesis for ER location that can then be confirmed by either ECoG or IEM.

  8. Imaging studies performed on patients with persistent seizures after resection of a lesion determined as epileptogenic, or surgical procedures such as callosotomy or functional hemispherectomy, should be compared carefully with preoperative studies. This comparison should examine for completeness of resection and for a second lesion that was not detected during the workup for the first procedure, particularly if the seizure semiology changes after the first surgical procedure.

Putting it all together

The summary of the information gathered from various non-invasive tests including neuroimaging studies should be analysed and discussed at multidisciplinary team meetings. This may entail amending prior interpretation of tests in the light of collective information. Subtle FCD lesions become apparent on MRI that has been reported as normal; this may be because of 3D reconstruction of multimodality data to assess convergence or plan intracranial electrode placement or surgical navigation. The case discussion is aimed at defining surgical candidacy, goals of the procedure chosen and guiding future patient management strategies. One of the key decisions at this conference is to decide between hemispherectomy versus tailored focal resection. In patients with extensive unihemispheric pathology such as hemimegalencephaly, Sturge-Weber syndrome and hemispheric stroke documented on MRI, no additional tests are generally required. In cases where the scalp EEG abnormalities appear more prominent over the contralateral normal hemisphere, the MRI should be carefully re-evaluated for subtle occult pathology. In some of these cases, the EEG findings may be falsely lateralising, particularly if the clinical semiology is clearly lateralised to the abnormal hemisphere and consistent with the MRI lesion. In these cases, the radiologist can help to reduce aggressive pursuit of additional unnecessary testing by clearing the contralateral hemisphere.

New MRI techniques include isotropic motion-compensated multi-echo T1W magnetisation-prepared rapid gradient echo sequence, diffusion tensor imaging and tractography maps, MR spectroscopy and arterial spin labelled images to assess perfusion without the need for contrast medium. Additional functional imaging with SPECT and/or PET and, in some cases, fMRI and MEG is also utilised in some cases (Figure 11).

FIGURE 11: Six-year-old boy presented with intractable seizures and left fronto-central EEG abnormality. Axial T2W (a) shows cortical thickening in the left frontal lobe (arrows). This is matched by hypoperfusion on the regional cerebral blood flow (reCBF) map (b) from the pulsed ASL acquisition and by decreased uptake of FDG on the PET scan (c).


Advances in neuro-imaging continue to improve the rates of detection of lesional substrates in paediatric patients with epilepsy. It is important to utilise tailored MRI protocols as described above on the best scanner hardware available. Further, a systematic and meticulous approach is key to evaluating these scans, which should be combined with information from other modalities at a multidisciplinary conference to define possible candidate lesions for surgical resection.


We are indebted to the Department of Epilepsy, Royal Children’s Hospital, Melbourne, Australia, and Boston Children’s Hospital, Boston, USA, and the RSNA Derek Harwood Nash International Fellowship 2013 which N.M. completed at Boston Children’s Hospital.

Competing interests

The authors declare that they have no financial or personal relationships which may have inappropriately influenced them in writing this article.

Authors’ contributions

S.P. (Boston Children’s Hospital) wrote the article and contributed all the cases. N.M. (University of the Witwatersrand) conceptualised the article, proposed the concept to the editor of the SAJR, adapted the article to a South African audience, edited the article and was responsible for addressing all the reviewers’ comments.

  1. Weaver DF, Pohlmann-Eden B. Pharmacoresistant epilepsy: Unmet needs in solving the puzzle(s). Epilepsia. 2013;54(Suppl 2):80–85. PMID: 23646978,
  2. Gaillard WD, Cross JH, Duncan JS, Stefan H, Theodore WH, Task force on practice parameter imaging guidelines for International League Against Epilepsy CfD. Epilepsy imaging study guideline criteria: Commentary on diagnostic testing study guidelines and practice parameters. Epilepsia. 2011;52:1750–1756. PMID: 21740417,
  3. Jayakar P, Gaillard WD, Tripathi M, et al. Diagnostic test utilization in evaluation for resective epilepsy surgery in children. Epilepsia. 2014;55:507–518. PMID: 24512473,
  4. Wieshmann UC. Clinical application of neuroimaging in epilepsy. J Neurol Neurosurg Psychiatry. 2003;74:466–470. PMID: 12640065,
  5. Von Oertzen J, Urbach H, Jungbluth S, et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry. 2002;73:643–647. PMID: 12438463,
  6. Blumcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011;52:158–174. PMID: 21219302,
  7. Leach JL, Miles L, Henkel DM, et al. Magnetic resonance imaging abnormalities in the resection region correlate with histopathological type, gliosis extent, and postoperative outcome in pediatric cortical dysplasia. J Neurosurg Pediatr. 2014;14:68–80. PMID: 24866708,
  8. Ng YT, McGregor AL, Duane DC, Jahnke HK, Bird CR, Wheless JW. Childhood mesial temporal sclerosis. J Child Neurol. 2006;21:512–517. PMID: 16948937,
  9. Benbadis SR, Wallace J, Reed Murtagh F. MRI evidence of mesial temporal sclerosis in subjects without seizures. Seizure. 2002;11:340–343. PMID: 12076108,
  10. Pinto A, Miller-Horn J, Guilhoto L, et al. Teaching neuroimages: Mesial temporal sclerosis after a prolonged unprovoked seizure in an infant. Neurology. 2011;77:e112–113. PMID: 22067970,
  11. Mittal S, Montes JL, Farmer JP, et al. Long-term outcome after surgical treatment of temporal lobe epilepsy in children. J Neurosurg. 2005;103:401–412. PMID: 16302611.
  12. Mohamed A, Wyllie E, Ruggieri P, et al. Temporal lobe epilepsy due to hippocampal sclerosis in pediatric candidates for epilepsy surgery. Neurology. 2001;56:1643–1649. PMID: 11425928.
  13. Kasasbeh A, Hwang EC, Steger-May K, et al. Association of magnetic resonance imaging identification of mesial temporal sclerosis with pathological diagnosis and surgical outcomes in children following epilepsy surgery. J Neurosurg Pediatr. 2012;9:552–561. PMID: 22546035,
  14. Eriksson SH, Thom M, Symms MR, et al. Cortical neuronal loss and hippocampal sclerosis are not detected by voxel-based morphometry in individual epilepsy surgery patients. Hum Brain Mapp. 2009;30:3351–3360. PMID: 19347875,
  15. Focke NK, Yogarajah M, Bonelli SB, Bartlett PA, Symms MR, Duncan JS. Voxel-based diffusion tensor imaging in patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Neuroimage. 2008;40:728–737. PMID: 18261930,
  16. Coan AC, Kubota B, Bergo FP, Campos BM, Cendes F. 3T MRI quantification of hippocampal volume and signal in mesial temporal lobe epilepsy improves detection of hippocampal sclerosis. Am J Neuroradiol. 2014;35:77–83. PMID: 23868151,
  17. Waelchli R, Aylett SE, Robinson K, Chong WK, Martinez AE, Kinsler VA. New vascular classification of port-wine stains: Improving prediction of Sturge–Weber risk. Br J Dermatol. 2014;171:861–867. PMID: 24976116,
  18. Prabhu SP. Imaging parameters are important to completely rule out Sturge-Weber syndrome. Pediatr Neurol. 2013;49:e1. PMID: 23827433,
  19. Thiele EA. Managing and understanding epilepsy in tuberous sclerosis complex. Epilepsia. 2010;51 Suppl 1:90–91. PMID: 20331728,
  20. Olson HE, Lechpammer M, Prabhu SP, et al. Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis. Epilepsia. 2013;54:1753–1760. PMID: 23980696,
  21. Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery. 1997;41:378–386; discussion 86–87. PMID: 925730.
  22. Ghatan S, McGoldrick P, Palmese C, et al. Surgical management of medically refractory epilepsy due to early childhood stroke. J Neurosurg Pediatr. 2014;14:58–67. PMID: 24866497,
  23. Statler KD. Pediatric posttraumatic seizures: Epidemiology, putative mechanisms of epileptogenesis and promising investigational progress. Dev Neurosci. 2006;28:354–363. PMID: 16943659,
  24. Christensen J, Pedersen MG, Pedersen CB, Sidenius P, Olsen J, Vestergaard M. Long-term risk of epilepsy after traumatic brain injury in children and young adults: A population-based cohort study. Lancet. 2009;373:1105–1110. PMID: 19233461,

Crossref Citations

No related citations found.